ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Long-Term Outcomes after Liver Transplantation for Wilson Disease: A Single-Center Experience

J. Lai, M. Schilsky, T. Schiano, A. Shirsat, J. Chu, R. Arnon

Division of Pediatric Hepatology and Recanati Miller Transplant Institute, Mount Sinai Medical Center, New York, NY
Division of Digestive Diseases, Yale New Haven Transplant Center, Yale University Medical Center, New Haven, CT
Division of Liver Diseases, Department of Medicine, Mount Sinai School of Medicine, New York, NY

Meeting: 2013 American Transplant Congress

Abstract number: A599

Background: Orthotopic liver transplantation (OLT) is indicated for patients with acute liver failure (ALF) or decompensated cirrhosis due to Wilson Disease (WD). Goal: To review the long-term outcomes of patients who underwent OLT for WD. Methods: A retrospective review of data on 22 patients with OLT for WD from 1988-2007 at a single tertiary center. Results: Demographics, mode of presentation, renal function and outcomes are presented in figure 1. Mean length of follow-up was 11.4 ± 6.2 years (range 1.0-23.4 years). All children presented with ALF. Three adults underwent OLT after stopping medical therapy. Two patients died from intra- or immediate post-operative complications. 40.9% of patients required hemodialysis prior to transplant. After transplant, no patients required chronic hemodialysis or received kidney transplantation. Neurologic complications of WD other than encephalopathy were present in one patient with chronic WD pre-transplant and completely resolved after transplant.

Conclusions: OLT provides excellent long-term survival for patients with ALF or decompensated cirrhosis due to WD. Renal dysfunction, common in pre-transplant WD patients, completely resolved after transplant.

  • Tweet
  • Email
  • Print

To cite this abstract in AMA style:

Lai J, Schilsky M, Schiano T, Shirsat A, Chu J, Arnon R. Long-Term Outcomes after Liver Transplantation for Wilson Disease: A Single-Center Experience [abstract]. Am J Transplant. 2013; 13 (suppl 5). https://atcmeetingabstracts.com/abstract/long-term-outcomes-after-liver-transplantation-for-wilson-disease-a-single-center-experience/. Accessed May 11, 2025.

« Back to 2013 American Transplant Congress

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences